Work

Phase II clinical and pharmacological study of didemnin B in patients with metastatic breast cancer

Year: 1992

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1007/bf00873128

Authors: John A. Benvenuto, Robert A. Newman, Gary S. Bignami, T. J. G. Raybould, Martin N. Raber, Laura Esparza, Ronald S. Walters

Institutions: The University of Texas MD Anderson Cancer Center, Hawaii Biotech (United States)

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G163364708, PHASE II/III CLINICAL TRIALS OF ANTICANCER AGENTS

OpenAlex ID: W2115749431

FWCI: 0.131

Cites: 13

Cited by: 35

Related to: 10